Biomarin Pharmaceutical Inc. (BMRN)
Market Closed
16 Oct, 08:00 PM
$
54. 68
-1.37
-2.4442%
$
10.85B Market Cap
126.18 P/E Ratio
- Div Yield
2.63M Volume
1 Eps
$ 56.05
Previous Close 
Want to track BMRN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Biomarin Pharmaceutical Inc. (BMRN) Statistics
Valuation metrics
Market Cap 10.85B
Enterprise value 13.92B
Trailing P/E (ttm) 144.2
Forward P/E 8.4
PEG ratio -1.62
Price/Sales (ttm) 3.11
Price/Book (mrq) 1.67
Enterprise Value/Revenue 4.09
Enterprise Value/EBITDA 36.09
Overview
Shares outstanding 193.27M
Float 192.17M
Shares short 10.79M
% Held by insiders 0%
% Held by institutions 1.03%
Average volume (10 days) 2.15M
Average volume (90 days) 1.65M
Price summary
52-Week low 49.26
52-Week high 70.98
Beta 0.23
50-Day moving average 60.62
200-Day moving average 55.55
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.02%
Operating margin 0.08%
Operational effectiveness
Return on assets 0.01%
Return on equity 0.01%
Income Statement
Revenue (ttm) 3.24B
Revenue per share (ttm) 17.65
Quarterly revenue growth (yoy) 0.03%
Gross profit (ttm) 1.66B
EBITDA 572.94M
Net income to common (ttm) 268.74M
Diluted EPS (ttm) 0.38
Quarterly earnings growth (yoy) -0.43%
Balance Sheet
Total cash (mrq) 2.22B
Total cash per share (mrq) 4.53
Total debt (mrq) 1.44B
Total Debt/Equity (mrq) 0.66
Current ratio (mrq) 2.39%
Book value per share (mrq) 32.76
Cash Flow
Cash flow statement 874.25M
Levered free cash flow (LFCF) 459.42M
2026 © Marketlog. All Rights Reserved.
